Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:2980-2987
Published online before print November 1, 2004, doi: 10.1161/01.CIR.0000146902.84099.26
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
110/19/2980    most recent
01.CIR.0000146902.84099.26v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, H.-H.
Right arrow Articles by Stewart, A. F.R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, H.-H.
Right arrow Articles by Stewart, A. F.R.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Medline Plus Health Information
*Arrhythmia
Related Collections
Right arrow Arrythmias-basic studies
Right arrow Physiological and pathological control of gene expression

(Circulation. 2004;110:2980-2987.)
© 2004 American Heart Association, Inc.


Arrhythmia/Electrophysiology

Transcription Enhancer Factor-1-Related Factor-Transgenic Mice Develop Cardiac Conduction Defects Associated With Altered Connexin Phosphorylation

Hsiao-Huei Chen, PhD; Catherine J. Baty, DVM, PhD; Tomoji Maeda, PhD; Steven Brooks, MD; Linda C. Baker, PhD; Takahisa Ueyama, MD, PhD; Erdal Gursoy, MD, PhD; Samir Saba, MD; Guy Salama, PhD; Barry London, MD, PhD; Alexandre F.R. Stewart, PhD

From the Cardiovascular Institute (H.-H.C., T.M., S.B., T.U., E.G., S.S., B.L., A.F.R.S.) and the Department of Cell Biology and Physiology (C.J.B., L.C.B., G.S.), University of Pittsburgh, Pittsburgh, Pa.

Correspondence to Alexandre F.R. Stewart, Cardiovascular Institute, School of Medicine, University of Pittsburgh, BST 1704.3, 200 Lothrop St, Pittsburgh, PA 15213. E-mail stewartaf{at}upmc.edu

Received February 9, 2004; de novo received April 27, 2004; revision received June 9, 2004; accepted June 10, 2004.

Background— Conduction system defects and slowed ventricular conduction are common in patients with systolic dysfunction and contribute to arrhythmias and sudden death. In animal models of heart failure, cardiac {alpha}1-adrenergic signaling is constitutively activated. Here, we report the effects of constitutive activation of {alpha}1-adrenergic signaling on connexin phosphorylation and cardiac conduction.

Methods and Results— Transgenic mice were generated with cardiac-specific overexpression of the transcription factor RTEF-1 (transcription enhancer factor-1-related factor), which mediates {alpha}1-adrenergic signaling in cardiac myocytes. Surface and intracardiac ECGs revealed prolongation of the PR, QRS, and AH intervals and the appearance of progressive atrial arrhythmias in RTEF-1 mice. Optical mapping using voltage-sensitive dye revealed slower conduction velocities across the atrial and ventricular myocardium. Intercellular dye transfer between RTEF-1 transgenic cardiac myocytes confirmed impaired conduction at the cellular level. Conduction defects were correlated with dephosphorylation of connexin40 and connexin43 and upregulation of protein phosphatase 1ß (PP1ß). Overexpression of PP1ß in HeLa cells dephosphorylated cardiac connexin. Confocal microscopy revealed increased levels of dephosphorylated connexin43 at the cardiac gap junctions in RTEF-1 mice, suggesting that defective conduction is a result of impaired gap-junction conductance rather than assembly.

Conclusion— Constitutive activation of {alpha}1-adrenergic signaling through the RTEF-1 transcription factor results in chronic elevation of PP1ß expression and connexin dephosphorylation. This mechanism may underlie some defects in cardiac conduction.


Key Words: gap junctions • transcription factors • ventricles • atrium • arrhythmias




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
T. Yoshida
MCAT Elements and the TEF-1 Family of Transcription Factors in Muscle Development and Disease
Arterioscler. Thromb. Vasc. Biol., January 1, 2008; 28(1): 8 - 17.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. E. Bondarenko and R. L. Rasmusson
Simulations of propagated mouse ventricular action potentials: effects of molecular heterogeneity
Am J Physiol Heart Circ Physiol, September 1, 2007; 293(3): H1816 - H1832.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Temple, P. Frias, J. Rottman, T. Yang, Y. Wu, E. E. Verheijck, W. Zhang, C. Siprachanh, H. Kanki, J. B. Atkinson, et al.
Atrial Fibrillation in KCNE1-Null Mice
Circ. Res., July 8, 2005; 97(1): 62 - 69.
[Abstract] [Full Text] [PDF]